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Cereals are suggested to be the most important sources of lignan in the diets of western populations. Recent epidemiological studies show that European 
subpopulations in which the major source of lignans are cereals, display lower disease frequency regarding metabolic and cardiovascular diseases. The 
biological mechanisms of lignan are several. Beyond their antioxidant and anti-inflammatory actions at nutritional doses some lignans regulate the activity of 
specific nuclear receptors (NRs), such as the estrogen receptors (ERs), and also NRs that are central switches in glucose and fatty acid metabolism such as 
PPAR, PPAR and LXRs, highlighting them as selective nuclear receptor modulators (SNRMs). These include enterodiol (END) and enterolactone (ENL), 
the metabolites produced by the gut microbiota from food lignans.  The available knowledge suggests that given some additional research it should be possible 
to make ‘function’ claims for a regular intake of lignans-rich foods related to maintaining a healthy metabolism. 
 




Introduction: Lignans are a group of compounds found in fiber-
rich foods such as cereals, oilseed, nuts, vegetables (brassica), and 
fruits (berries) typically regarded as components of healthy diets  
[1-3]. They are expected to have antioxidant, anti-inflammatory and 
hormone-mimicking effects in humans both as native compounds 
and after fermentative conversion in the colon [4-7]. 
 
Intakes of lignan-rich foods have been shown to be correlated with 
a lower incidence and progression of diseases / health conditions 
related to the metabolic syndrome, type 2 diabetes, cardiometabolic 
risk factors, specific types of cancers and overall mortality [8-12]. 
The most studied food sources rich in lignans, such as oilseeds 
(flaxseed and sesame seeds), cereals, and in particular cereal fibers, 
may contain sufficient concentrations of specific lignans to exert 
functional effects in humans. Amongst cereals, wheat and rye 
contain the highest concentration of lignans, mostly in their bran 
fraction. The most abundant lignans here are 7-hydroxymatairesinol 
and syringaresinol [14, 15]. 
 
Recent studies have highlighted some of the possible mechanisms 
of action of lignans. Almost all are endowed with antioxidant and 
anti-inflammatory activities. However, some of these compounds 
have also shown the ability to bind and activate/inhibit nuclear 
receptors (NRs) such as the estrogen receptors (ERs) [7], the 
peroxisome proliferator activate receptor gamma (PPAR) [16], and 
the liver X receptor alpha (LXR) [17]. The regulation of gene 
expression through these receptors may require the metabolization 
of most plant lignans to the mammalian lignans enterodiol (END) 
and enterolactone (ENL) [18], while some lignans like 7-
hydroxymatairesinol are shown to engage NRs also in their 
unmetabolized form [19]. Metabolization of lignans requires gut 
microbial processes to release them from the food matrix and 
undergo deglycosylation in the intestine and conversion in the liver 
to active metabolites. Several of the lignans that have been studied 
so far have shown interesting roles in promoting human health. 
Some of them were identified in plants to be of pharmaceutical and 
cosmetic interest although the diet remains the major route of intake 
of these chemicals [5, 13, 20, 21]. In particular cereal lignans are 
present in high amounts in the daily diet of western populations and 
are likely to be the dietary plants that provide most of the beneficial 
bioactive lignans in Europe, the US and Canada [5, 13, 20, 21]. Here 
we review the recent and ongoing research on the characterization 
of the health effects of cereal lignans and their mechanisms. 
 
Methods: A comprehensive computer literature search of the Pub- 
Med/MEDLINE, Embase and Scopus databases was conducted to 
find relevant published articles about the role of lignans in health. 
No beginning date limit was used; the search was updated until 
January 2016. Only articles in the English language were selected. 
To expand our search, references of the retrieved articles were also 
screened for additional studies. 
 
Lignan chemistry and biochemistry: The chemistry of lignans has 
been studied for the past 65 years. They possess very different 
structural composition and can be found in nature in vegetables, 
mostly in exudates and resins, although they can be present in 
different parts of the plant. Lignans are polyphenolic substances 
derived from phenylalanine via dimerization of substituted 
cinnamic alcohols, known as monolignols, to a dibenzylbutane 
skeleton and they are found mostly in plants as aglycones, esters or 
glycosides. These dimeric phenylpropanoids show two C6-C3 units 
attached to the central carbon C8 while, when two phenylpropanoid 
units are found coupled in a different manner, like C5-C5’, the new 
term “neolignan” has been adopted (Figure 1) [22].  
 
The lignans can be classified into eight chemical groups and several 
subgroups based upon the way in which oxygen is incorporated into 
the skeleton and on the cyclization pattern [22]. Lignan subgroups 
arise via the shikimic acid pathway from the reduction of cinnamic 
acid derivatives produced from aromatic aminoacids (L-
phenylalanine and L-tyrosine) and subsequently reduced via 
coenzyme A to alcohols that are the main precursors of all lignans 
(p-coumaryl alcohol, coniferyl alcohol and sinapyl alcohol) in 
plants. The enantioselective dimerization of two coniferyl alcohol 
monomers via intermolecular 8,8’ oxidative coupling, generate 
pinoresinol, a major lignan in food seeds and grains [23]. 
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Figure 1: Basic structure of lignans. a and b) The propylbenzene skeleton and the 
dibenzylbutane skeleton of lignan attached C6-C3 to the central carbon C8.  c) Two 
phenylpropanoid units of a neolignan coupled  C5-C5’. 
 
Subsequent metabolization steps generate lariciresinol and 
secoisolariciresinol through pinoresinol/lariciresinol reductase and 
secoisolariciresinol dehydrogenase respectively. 
Secoisolariciresinol is the common precursor of all 
dibenzylbutyrolactol lignans including matairesinol, yatein and 
aryltetralin lignans (Figure 2). These subclasses of lignans includes 
some important bioactive chemicals from which several structural 




Figure 2: Major lignans in oilseeds and cereals. Secoisolariciresinol is the common 
precursor of all dibenzylbutyrolactol lignans.  These subclasses of lignans include some 
important bioactive chemicals from which several structural analogues have been 
derived, studied and employed as pharmaceuticals [24]. 
 
Lignans can be converted by intestinal microbiota, under strictly 
anaerobic condition, to the mammalian lignans, enterodiol (END) 
and enterolactone (ENL). These compounds, also called 
enterolignan, following metabolization steps in the gut acquire 
specific bioactivities and healthy effects, some of which have been 
shown to occur through the interaction with nuclear receptors [18]. 
The biotransformation of plant lignans to enterolignan has been 
extensively studied with secoisolariciresinol (SDG) through the 
pathway consisting of glycoside hydrolysis, demethylation and 
dehydroxylation and intermediates [25]. The metabolization steps 
will be further discussed in the last paragraph of this review in a 
more detailed manner. 
 
Lignans in nutrition, availability and food sources: Several of 
the lignans under study are present in plants of a very different kind 
throughout the whole plant kingdom. Some of them are highly 
concentrated in plants of medical interest, i.e. Podophyllum species 
containing podophyllotoxin, which is particularly interesting for its 
anticancer properties [24, 26]. High concentrations of lignans are 
also found in plants of nutritional interest. The richest are by far 
oilseeds such as flaxseed and sesame, with concentrations up to 1% 
of the seed weight. These seeds are consumed in functional amounts 
in defined geographical regions of the world, in particular the 
Middle East, North Africa and Asia. 
 
Cereals, nuts, broccoli (Brassica species), fruits, berries and 
beverages (tea, coffee, beer wine) are suggested to be the most 
important sources of lignans in the diets of Europeans. According to 
a Dutch lignan database, the average daily intake of lignans in the 
Netherlands was 1000 to 2000 µg/day and in the Finnish population 
1081 µg/day, ranging from 1136 µg/day for men to 1036 µg/day for 
women) [13]. In another study in the Finnish population the average 
lignan intake based on urinary excretion of lignan was 1224 µg/day 
[27]. Sweden registered the highest intake in Europe with 1773 
µg/day total lignans for women and 1947 µg/day for men. Intakes 
between 1062 and 1188 µg/day have been reported in south Europe 
(Italy) [13] and 600 µg/day in the USA (Breast Cancer and 
Environment Research Project Puberty Study) [28]. Higher levels of 
intake (up to 13.5 mg/day) have been reported in previous studies in 
the USA and Canada [21]. In the east, a Chinese study reported 
intakes measured through the urinary excretion of mammalian 
lignans giving values in the range of 0.30 and 1.18 nmol/mg 
creatinine of enterodiol and enterolactone, respectively. The levels 
of enterodiol were two-fold higher in the Chinese population 
compared with US women in a similar age range, while 
enterolactone was observed at similar levels in both populations 
[29].  
 
Cereal lignans: Up to date, the most investigated lignans have been 
extracted from food sources such as flaxseed and sesame seeds, the 
first being known as the richest food source of the lignan 
secoisolariciresinol and the latter being the most consumed lignan-
rich food in the world with a unique lignan composition. However, 
in the western countries cereals are the major source of lignans 
(because of their regular daily consumption) with an impact that 
may influence human health (Table 1).  
 
Wheat: Wheat is the most consumed cereal in the diet in Europe, 
the USA, and Canada. It is well accepted and has an attractive low 
price as food, but also as a lignan source. By wheat milling  the 
grain is split into two major parts, the flour (about 70-80%), and the 
bran fraction, which is approximately 15%. This last fraction 
contains most of the grain lignans (70-85%), which are mostly 
situated within the aleurone cells, the single cell layer at the inner 
site of the bran. 
 
Novel milling and dry-fractionation techniques and new extraction 
and analytical methods have recently allowed full-scale separation 
of aleurone cells from the other layers of wheat bran, yielding a 
fiber rich concentrate which contains many nutrients and  well- 
known bioactive lignans, as well as several new ones with potent 
bioactivity (Figure 3) [31, 32]. 
 
 
Figure 3: A schematic representation of the fractionation of cereal bran (approximately 
15% of the grain). Most of the grain lignan (70-85%) is situated within the aleurone, 
the single cell layer at the inner site of the bran. Separation of the aleurone cells from 
the other layers of the cereal bran yields a fiber rich concentrate which, beyond well-
known and new lignans, contains many other nutrients. 
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Table 1: Concentration of main lignan in different food sources. 
 
Altogether, wheat grains may contain up to 1 mg lignans/100 g and 
the large majority of these reside in the bran layer containing  up to 
20 mg lignans /100 g bran. 7-Hydroxymatairesinol and 
syringaresinol are the dominant lignans in wheat although 
secoisolariciresinol, lariciresinol, matairesinol and other less 
characterized lignans, such as 7-oxomatairesinol are also present in 
variable concentrations depending on the variety [33, 34] (Table 2).  
 
Table 2: Concentration of total lignans in wheat bran and rye bran. 
 
Different varieties of wheat have been profiled for their content of 
lignans. In a work by Dinelli et al. [35], old and modern Italian 
wheat varieties cropped in the same location and growing season 
have been analyzed. The study shows that both free and bound 
phenols are very variable in content and, on the average, the bound 
fraction contributed 72.0% to the total phenolic content. The 
obtained metabolomic fingerprints showed the presence of several 
classes of compounds which included flavonoids, coumarins, 
stilbenes, proanthocyanidins and lignans, some of which may have 
health promoting effects. The HPLC-ESI-TOF-MS analysis 
identified 104 compounds and also highlighted remarkable 
differences in the phytochemical fingerprints of old and modern 
wheat varieties. Six ancient wheat genotypes (Bianco Nostrale, 
Frassineto, Gentil Rosso, Gentil Rosso Mutico, Marzuolo d'Aqui, 
Verna) showed phenolic profiles with a number of total compounds 
and isomer forms including the lignan syringaresinol, with much 
higher contents than in the modern cultivars, indicating that they 
might be better sources of phenolic compounds with added value in 
terms of potential health-promoting components [35]. 
 
Rye: Among cereal grains, rye has the highest concentration of 
lignans, mostly as glycosides which, like in wheat, are concentrated 
in the outer layers of the kernel [36]. The most abundant are 
pinoresinol, syringaresinol, 7-hydroxymatairesinol, lariciresinol and 
isolariciresinol. When considering the whole rye grain, 7-
hydroxymatairesinol is the dominant lignin, followed by 
syringaresinol (Table 2).  
 
In studies aimed at identifying novel urinary biomarkers of 
wholegrain rye bread intake versus refined wheat bread, the 
profiling of several metabolites, including END and ENL, allowed 
the identification of wholegrain rye as a food source providing a 
higher concentration of urinary phenols [37]. In their study, Bondia-
Pons et al. experimentally found higher levels of five lignans after 
intake of wholegrain rye bread than after intake of refined white 
bread. This was associated with a lower fasting plasma insulin level 
and lower 24-h urinary C-peptide excretion [37]. The highest 
concentration of plasma and urinary levels of entrolignans have 
been measured in subjects traditionally consuming wholegrain rye 
at the highest amounts in North and East Europe, Russia and China, 
where the production of rye is mostly concentrated (1 to 4 million  
tons/year).  
 
Cereal consumption and bioprinciples of accessibility: 
Regarding the nutritional aspect of cereal grains and bran, studies 
suggest that whole grains have superior nutritional values compared 
with foods enriched with fibers. This is because the bioactive 
components are more abundant in the whole grain and particularly 
concentrated in the aleurone layer. Moreover, beyond lignans, the 
bran fraction of cereals contains most of the micronutrients and 
complex carbohydrates of the grains, in particular beta-glucans and 
arabinoxylans, which are promising nutraceuticals. Nonetheless, as 
recently evidenced by an EU study consortia on European 
cohorts, the consumption of whole seeds or grains supposed to 
provide health benefits, often does not fulfil the expectations 
(www.healthgrain.eu). This might be due to the fact that although 
cereals are good sources of lignans, their bioabsorption from the 
consumption of the whole grains is limited. This is likely due to 
their macro- and microstructure and consequently texture of the raw 
flour which influences their functionality in the gastrointestinal 
tract, specifically component absorption, bioavailability, and 
metabolization to enterolignans [38]. The studies carried out by 
two groups in the Healthgrain consortium working on wholegrain 
products, including wheat, showed in fact that subjects consuming 
whole grains did not achieve significant changes in traditional 
biomarkers of MetS (www.healthgrain.eu). It is now known that 
this is partially due to the inaccessibility of the bioactive 
principles contained in the natural matrices because of their 
insufficient breakdown and digestion but also absorption. The 
major problem identified by bioavailability studies was the poor 
bioaccessibility of the active principles. Two studies from Anson 
et al. [39, 40], evidenced that release and conversion of phenolic 
acids to their microbial metabolites was enhanced by 
bioprocessing of wheat bran to more bioavailable formulations. In 
the bioprocessed bread, the bran was processed by yeast 
fermentation combined with enzyme treatment, consisting of cell-
wall-degrading enzymes, mainly xylanase, cellulase, glucanase and 
feruloyl-esterase [40]. 
 
Nutritional impact on health of lignans. The metabolic 
syndrome (MetS): The high prevalence of MetS and excessive 
adipose tissue accumulation (in particular, abdominal obesity) is a 
major threat to public health, being associated with a substantial 
decrease in health-related quality of life and an increase in 
economic costs due to disease treatment, as well as lower social 
productivity. 
 
MetS is a multiplex and life-based risk factor that consists of  
several correlated risks of metabolic origin. In addition to 
dyslipidemia, hypertension and hyperglycemia, the syndrome 
carries a proinflammatory state [41]. Subjects affected by         
MetS are at increased risk of cardiovascular diseases                     
(2-fold), type-2 diabetes (5-fold), gallbladder disease, certain    
types of cancer and psychosocial problems (www.lipgene.tcd.ie, 
 Lignan (µg/100 g) 
Food sources Pinoresinol Syringaresinol Lariciresinol Secoisolariciresinol Matairesinol 7-Hydroxymatairesinol Sesamine 
Flaxseeds 871 48 1780 165759 529 35 ND 
Sesame 47136 205 13060 240 1137 7209 62724 
Rye bran 1547 3540 1503 462 729 1017 ND 
Wheat bran 138 882 672 868 410 2787 ND 
Oat bran 567 297 766 90 440 712 ND 
Barley bran 71 140 133 42 42 541 ND 
Wheat bran Amounts of total lignan 5-20 mg/100 g (depending on the variety) 
 Total lignan 7-hydroxymatairesinol, syringaresinol, secoisolariciresinol, 
lariciresinol, matairesinol  
 New lignan Iso-hydroxymatairesinol, 7-oxomatairesinol   
 
Rye bran Amounts of total lignan 10-20 mg/100 g (depending on the variety) 
Total lignan syringaresinol, pinoresinol, lariciresinol, isolariciresinol,   
7-hydroxymatairesinol, matairesinol, secoisolariciresinol. 
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www.nutrition.org.uk/lipgene, www.oecd.org.) [42]. More than 130 
million Europeans are estimated to have MetS and 56 million type-2 
diabetes [43] and the numbers are estimated to increase for the next 
decades. Thus, MetS is ‘the’ major health challenge in Europe and 
the western countries today but further, the same tendency is also 
seen in many less developed countries, e.g. India. New strategies 
and very extensive research and initiatives related to the long-term 
prevention and reduction of incidence and severity of cardiovascular 
diseases, type-2 diabetes and obesity have been undertaken by the 
EU Commission and the WHO for both prevention and cure, to halt 
the problem [44-46]. Amongst the identification of fields of 
intervention, the better characterization of the bioactive compounds 
within many foods seems to be a promising area. In fact, although 
poor diets and physical inactivity are the driving forces behind 
MetS, appropriate dietary strategies may positively impact on 
disease predisposition and evolution. 
 
For the assessment of the nutritional effects of lignan consumption 
on human health, different European networks such as the EPIC-
Potsdam Study have been particularly suited to serve as 
epidemiological reference cohorts for results comparison. They 
have been recently used to investigate the role of lignans on disease 
occurrence using medically verified data. The analyzed endpoints of 
chronic diseases following lignan intake were: a) incidence of the 
metabolic syndrome (NHANES-National Health and Nutrition 
Examination Survey [47]; b) type-2 diabetes (EPIC-InterAct Study) 
[9]; c) cardiometabolic risk factors (NHANES) [11]; d) specific 
types of cancers (DietCompLyf Study) [12]; (EPIC Study) [10, 48-
51], (EPIC-Norfolk) [52-54]; and e) overall mortality (EPIC-Spain) 
[10]. From these studies it is apparent that European subpopulations 
in which the major source of lignans is cereals [9], display 
considerable lower disease frequency and beneficial effects in the 
control of metabolic diseases like dyslipidemia and type-2 diabetes. 
Further, other recent observations in different populations report 
that lignan intake is associated with lower levels of triglycerides, 
lower fasting glucose, and fasting insulin serum levels in males 
aged 20-60 years. These data are associated with higher HDL-
cholesterol levels [2, 11, 29, 55-58]. Some studies have also been 
conducted in animal models in which partially purified lignan 
fractions have been shown to improve blood lipids and glycemic 
control [59, 60]. The results from all these studies underline the 
need to understand better the mechanisms of action of these 
compounds in maintaining a healthy metabolism.  
 
Mechanisms of lignans on health: Although impressive advances 
have been seen in the last years as regards the mechanisms of action 
for the most thoroughly investigated dietary polyphenols (lignans, 
stilbenes, isoflavones, etc.), most of their health-related effects have 
been attributed to their activity as antioxidants [61, 62]. However, a 
certain amount of data is now becoming available on the activity of 
these compounds at doses lower than those required to exert 
biological antioxidant activities, but sufficient to activate 
fundamental cell pathways, several of which are regulated by the 
nuclear receptors (NRs). The availability of data regarding the 
regulation of different NRs at relatively low doses, stimulated the 
characterization of the effects of lignans in tissues and cells at doses 
that are consistent with the doses reached in the blood through the 
diet (nutritional doses) [7, 18]. Among others, it has  been shown 
that, at nutritional doses, some lignans can regulate the activity of 
specific NRs such as the estrogen receptors (ERs) with an efficiency 
that in some cases approximate to that of the endogenous ligand 
17ß-estradiol [18]. This highlighted the importance of their actions 
as hormone mimics suggesting that they are effective on several 
physiological functions. Based on these observations, molecular and 
cellular studies are now starting to support the data provided by 
epidemiological studies and dietary interventions. Significant 
effects have in fact been shown for regulatory mechanisms related 
to lipid metabolism, glucose homeostasis, cholesterol biosynthesis 
and insulin biosynthesis and secretion, [18, 60, 61, 63-65]. 
 
Several data on lignans as estrogenic compounds regulating ER-
dependent pathways have been published [19, 66]. However, recent 
progress in the area  indicate that the term “phytoestrogen” may be 
poorly representative of the complex activities of lignans when 
considering as functional targets metabolic functions regulated 
through the ERs in the liver or adipose tissues, and not 
representative at all when considering lignan activity through 
metabolic sensors like the peroxisome proliferator-activated 
receptors. It is in fact becoming frequent to observe that the same 
molecules that regulate the ERs, also regulate other NRs that play 
fundamental actions in metabolic tissues. The engagement and 
regulation of PPAR, PPAR and LXRs that are central regulators 
of glucose metabolism, fatty acid metabolism and insulin action, 
evidence the lignans as real SNRMs (Selective Nuclear Receptors 
Modulators). Known examples are the flaxseed lignan 
secoisolariciresinol diglucoside (SDG), which can regulate the ERs 
[6], PPARs [67] and LXRs [17], and unpublished observations. A 
lignan isolated from medicinal plants, honokiol [68], is a non-
adipogenic PPAR agonist [69] and a ligand of the adipogenic 
RXRß receptor [70]. Meso-dihydroguaiaretic acid (MDGA), a 
major component of Myristica fragrans, a traditionally used food 
spice in several countries [71], competes with the LXR agonist 
T0901317 for binding to the LXR domain [17]. The sesame 
lignans sesamin and episesamin, can stimulate fatty acid synthesis 
and oxidation in the liver via activation of PPAR, can attenuate 
nutritional fibrosing steatohepatitis through up-regulation of PPAR 
[72], down-regulate PPAR antiinflammatory effects in 3T3-L1 
preadipocytes [16], and can suppress macrophage-derived 
chemokine expression in human monocytes via epigenetic ER- and 
PPARmediated regulation [73]. The mammalian enterolignans, 
enterodiol (ENL) and enterolactone (END) generated through the 
metabolization of dietary lignans by the intestinal microbiota bind 
both the ERs [18] and likely the LXRs, as evidenced by 
unpublished in silico studies (personal communication from 
Ingemar Pongratz). Activity has also been reported for (+)-
pinoresinol through the negative regulation of the human thyroid 
hormone receptor ß [74], likely interfering with adipose cell 
differentiation [75]. Negative regulation has also been shown by 
ENL through the androgen receptor (AR) and by sesamin through 
the pregnane X receptor (PXR), while secoisolariciresinol and ENL 
are able to activate PXR in reporter assays suggesting an effect in 
the metabolism of CYP3A substrates [76]. A few cereal lignans 
have also been tested in vitro and found to be effective inhibitors of 
adipocyte differentiation. Pinoresinol, cycloisolariciresinol, 
lariciresinol, seicoisolariciresinol in the concentration range of 1-
1000 nM, are effective in inhibiting 3T3-L1 cell differentiation [77] 
and although their fine  mechanism of action has still to be clarified, 
it is likely that it involves the ability to regulate nuclear receptors 
such as PPARs, ERs and LXRs [65, 78, 79]. 
 
Microbial metabolization of lignans: Lignans occur in food in the 
form of esters, glycoconjugates, and polymers. These compounds 
are not directly bioavailable and require metabolic steps which 
involve both mammalian (glucuronidation and to a lesser degree, 
sulfation) and gut microbial processes [80]. When lignan glycosides 
are consumed with the diet, they are released from the matrix after 
mastication, are deglycosylated and are converted in the liver to 
glucuronidated [81], methylated and sulfated derivatives [82] that 
can be identified in human urine [83], but also to enterodiol and 
enterolactone by the intestinal microbiota [20] (Figure 4).  
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Figure 4: Mammalian lignans. The enterolignans (or mammalian lignan) enterodiol 
(END) and enterolactone (ENL) are lignan metabolites that are produced in the 
intestine from plant lignans by the gut microbiota. 
Probiotic lactobacilli and bifidobacteria, which have evolved within 
the colonic ecosystem where indigestible oligo- and polysaccharides 
are their sole carbon sources, bear several glycosyl-hydrolases and 
can contribute to the release of the aglycones from glycoconjugated 
phytochemicals [80]. β-Glucosidase-positive probiotic bacteria were 
proved to release the aglycones of lignans in vitro [84]. Despite the 
structural diversity of food lignans and their very different plant 
origins (i.e. oily matrices versus cereal bran), lignans are converted 
to enterolignans by the gut microbiota [20]. Following 
metabolization, enterodiol and enterolactone may reach a level high 
enough for signal pathway regulation in the liver, lung, kidney, heart 
and brain tissues [83] and pharmacokinetic studies show that these 
microbial metabolites have high systemic clearance and short half-
lives in the blood circulation, before being excreted as hepatic 
conjugates with the urine [85]. Dietary consumption of probiotics 
and limited digestible or indigestible food constituents such as 
oligosaccharides (prebiotics) and polyphenols or both (synbiotics), 
regulate the numbers and types of microbes which can influence 
energy utilization from the diet and regulate energy expenditure and 
storage. However, the genera of the microbiota that contribute to the 
metabolism of lignans are not yet sufficiently characterized, 
although investigations are underway and some gut microbiota 
strands have been identified as major lignan metabolizers in humans 
[86] and in animals [4, 87] and may thus represent possible 
beneficial factors for health. Associations are starting to be reported 
between the composition of the intestinal microbiota, lignan 
metabolites and the risk of diseases. Recent results suggest that 
urinary levels of ENL and/or END are associated with a lower risk 
of type 2-diabetes in US women [5], inflammation [88] and obesity 
and metabolic alterations in US men [55], and to the inhibition of 
inflammation and pro-carcinogenic microenvironments in animal 
tissues [66]. 
 
Conclusions: Today, more than 20 different lignans have been 
identified in seeds and cereals consumed as food worldwide and 
many others are found in cosmetic and medicinal plants [89]. Many 
of these have not been studied before and may possess potent 
biological activity, but also, amongst the most studied ones, data are 
not sufficient to draw definitive considerations for the present. 
However, the health effects of the most abundant food lignans in 
ameliorating different chronic diseases and related co-morbidities 
are being extensively characterized regarding absorption, 
bioavailability and activity following intake of whole foods, 
enriched foods, and fractions and extracts. Although so far most of 
these studies deal mainly with oilseeds lignans, an increasing 
number of observations indicate that regular intakes of wholegrain 
cereals and their products may exert a level of protection not 
observed with the ingestion of refined cereals, and recent research 
suggests that part of these effects may well be contributed by the 
lignan components [90]. 
 
To conclude, the reviewed body of research suggests that given 
additional efforts in clinical trials, it may be possible to make 
‘function’ claims for lignans related to maintaining a healthy 
metabolism and the prevention/amelioration of the metabolic 
syndrome and related pathologies. Importantly, this effect may be 
elicited through mechanisms that involve their direct 
agonistic/antagonistic action with different types of nuclear 
receptors. 
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